Bain Capital, LP is one of the world’s leading private investment firms with approximately $185 billion of assets under management that creates lasting impact for our investors, teams, businesses, and the communities in which we live. Since our founding in 1984, we’ve applied our insight and experience to organically expand into several asset classes including private equity, credit, public equity, venture capital and real estate. We leverage our shared platform to capture cross-asset class opportunities in strategic areas of focus. With offices on four continents, our global team aligns our interests with those of our investors for lasting impact.

Bain Capital Investor Portal Please log in to access your account information. If you have any questions regarding your account, please contact ir@baincapital.com.

Allyson S. Rinderle

Allyson S. Rinderle

Managing Director
Life Sciences
Boston

Experience

Ms. Rinderle joined Bain Capital in 2022. She is a Managing Director on the Bain Capital Life Sciences team. Prior to joining Bain Capital, she was a Principal at KKR within the Healthcare Growth Equity and Private Equity teams where she focused on the life sciences. Before KKR, Ms. Rinderle was a Vice President at Longitude Capital, a healthcare venture growth firm where she focused on biopharmaceutical investments. Prior to that, she was an Analyst at Aisling Capital, a life sciences investment firm, as well as an Analyst in J.P. Morgan’s Health Care Investment Banking practice.


Education

Ms. Rinderle holds an M.B.A. from Stanford Graduate School of Business, where she was an Arjay Miller Scholar. She received her B.S. in Biomedical Engineering with distinction from Yale University graduating magna cum laude, Tau Beta Pi, and Phi Beta Kappa.